Clarisa Hammer, DO
Plastic and Reconstructive Surgery · Alexandria, VANPI 1386764504
Payments from drug & device makers
What this record shows
13 manufacturers reported payments, led by AbbVie at 51.2% of the total. Reporting peaked in 2021 at $2,150 and has fallen 93.8% since, to $133 in 2025.
Across 38 payments — averaging $139.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Medical Device Business Services, Inc.$1K
- Myriad Genetic Laboratories, Inc.$221
- Vector Surgical, LLC$200
- Integra Lifesciences Corporation$181
- Sientra, Inc.$170
- plus $509 from 7 others
What the payments were for
- Travel & lodging$2,82153%
- Food & beverage$2,46847%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 20 | $2,707 |
| Medical Device Business Services, Inc. | 4 | $1,301 |
| Myriad Genetic Laboratories, Inc. | 2 | $221 |
| Vector Surgical, LLC | 1 | $200 |
| Integra Lifesciences Corporation | 1 | $181 |
| Sientra, Inc. | 2 | $170 |
| Smith+Nephew | 1 | $139 |
| Coopersurgical, Inc. | 1 | $134 |
| Axogen | 2 | $90 |
| Innovation Technologies Inc | 1 | $88 |
| Mentor Worldwide LLC | 1 | $26 |
| Solventum Corporation | 1 | $18 |
| Kls-martin L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,288 in reported general payments places this provider in the 70th percentile of 77 plastic and reconstructive surgery providers in Virginia.
See all plastic and reconstructive surgery providers in Virginia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cephalexin | 23 | $193 |
| Fluconazole | 30 | $123 |
| Oxycodone Hcl | 25 | $91 |
| Pentoxifylline | 11 | $75 |
Paid to pharmacies, not to this prescriber.
Other plastic and reconstructive surgery in Alexandria
- Reza KordestaniAlexandria$3K
- Lindsay JonesAlexandria$2K
- Susan BuenaventuraAlexandria$1K
- Rachel ParkAlexandria$891
- Maurice NahabedianMc Lean$828K
- Mark VenturiMc Lean$356K
- Neil ZemmelRichmond$38K
- Lauren NigroRichmond$28K
- Burton SundinRichmond$23K
- Vinod ChopraChantilly$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.